InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OMEROS CORP

OMER Clue Score25
United States Fiscal year ends December CIK 0001285819 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
David J. Borges
23 Sep 2026
VP, Finance & CAO
Sold after exercise
10,000
$20.95
$209.50K
David J. Borges
22 Sep 2026
VP, Finance & CAO
Sold after exercise
10,000
$20.95
$209.50K
Peter B Cancelmo
31 Aug 2026
VP, General Counsel
Sold after exercise
25,000
$18.54
$463.54K
Peter B Cancelmo
28 Aug 2026
VP, General Counsel
Sold after exercise
25,000
$18.65
$466.13K
Arnold C Hanish
27 Aug 2026
Director
Sold after exercise
5,000
$19.02
$95.08K
Arnold C Hanish
27 Aug 2026
Director
Sold after exercise
5,000
$18.88
$94.38K
Arnold C Hanish
26 Aug 2026
Director
Sold after exercise
5,000
$18.53
$92.63K
David J. Borges
24 Aug 2026
VP, Finance & CAO
Sold after exercise
906
$19.10
$17.30K
David J. Borges
21 Aug 2026
VP, Finance & CAO
Sold after exercise
10,000
$18.95
$189.50K
Thomas J. Cable
20 Aug 2026
Director
Sold after exercise
15,000
$18.45
$276.77K
David J. Borges
13 Aug 2026
VP, Finance & CAO
Sold after exercise
5,000
$16.95
$84.75K
Thomas J. Cable
22 May 2026
Director
Sold after exercise
7,500
$11.61
$87.04K
David J. Borges
13 Jan 2026
VP, Finance & CAO
Sold after exercise
30,000
$12.31
$369.32K
Show all 15 transactions →

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 13
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 911,084
History held since 13 Oct 2009